Stefano Pompei - MD Director Plastic and Reconstructive Surgery Unit San Camillo General Hospital Rome, Italy

The use of ADM (acellular dermal matrices) and synthetic meshes in breast surgery is gaining popularity in the last few years. In implant based BR, complete implant coveragehas been the main target of surgeons in order to reduce the risk of implant exposure. However, concerns regarding the significant cost associated with ADM have beenexpressed especially when compared with the synthetic meshes. Infection rate with ADM in literature ranges from 3.0 to 28.9%. Moreover, seroma incidence rate range from 1.5 to 29.9%. The Author reports the clinical experience with in the use of a synthetic 100% bioresorbable surgical mesh (Tigr Matrix, Novus Scientific, Uppsala, Sweden) in breast reconstruction as well in breast aesthetic surgery. Tissue expander with mesh (2 stage BR) or DTi (Direct-to-implant) with mesh was performed immediately after mastectomy. Similarly the Author describes the use of Tigr Matrix in secondary/revisional cosmetic surgery as well different indications for mastopexy/reduction without implants. In a total of 60 devices, the overall complications was 5.4%. The infection rate was 1.6% while seroma was observed in 3.3%. In the Author preliminary encouraging experience, Tigr Matrix mesh provides, with a limited cost and low morbidity, an effective implant or TE support in Breast Reconstruction as well with the soft tissues in difficult primary or revisional breast cosmetic surgery